22.20新台幣0.2(0.89%)
2023/05/30更新
績效 / 1月3.81%
3月2.4%
1年4.72%
晨星評等 - 1.現金1.93%
- 2.股票21.05%
- 3.債券0.00%
- 4.其他77.02%
- 1.美國76.87%
- 2.歐洲不包含歐元區10.95%
- 3.英國6.10%
- 4.日本3.54%
- 5.歐元區0.46%
- 1.Eli Lilly and Co8.79%
- 2.Regeneron Pharmaceuticals Inc8.75%
- 3.Novo Nordisk A/S Class B6.70%
- 4.UnitedHealth Group Inc6.51%
- 5.AbbVie Inc6.36%
- 6.AstraZeneca PLC6.10%
- 7.Gilead Sciences Inc5.71%
- 8.Biogen Inc5.01%
- 9.Vertex Pharmaceuticals Inc4.31%
- 10.Johnson & Johnson3.84%
- 1.現金1.93%
- 2.股票21.05%
- 3.債券0.00%
- 4.其他77.02%
- 1.美國76.87%
- 2.歐洲不包含歐元區10.95%
- 3.英國6.10%
- 4.日本3.54%
- 5.歐元區0.46%
- 1.Eli Lilly and Co8.79%
- 2.Regeneron Pharmaceuticals Inc8.75%
- 3.Novo Nordisk A/S Class B6.70%
- 4.UnitedHealth Group Inc6.51%
- 5.AbbVie Inc6.36%
- 6.AstraZeneca PLC6.10%
- 7.Gilead Sciences Inc5.71%
- 8.Biogen Inc5.01%
- 9.Vertex Pharmaceuticals Inc4.31%
- 10.Johnson & Johnson3.84%